TP53 and breast carcinoma: Accordingly, we found TTK to be significantly overexpressed in breast cancers that express mutant p53 as compared to their wild-type expressing counterparts, an association that occurred independent of breast cancer subtype (Figure 2a; METABRIC data set19).